bluuebunny/crossref_metadata_2025_split huggingface dataset:
Realisation of one‐dimensional (Si/SiO2)N PC filter in visible light band
Authors: Yang Yibiao , You Yi , Zhao Xiaodan , Chen Zhihui , Zhang Mingda , Fei Hongming 
Published: August 2018

The work proposes a one‐dimensional photonic crystal (PC) filter with (Si/SiO2)N structure, which is used to filter in the visible light band. The optical properties are simulated theoretically by using the transfer matrix method. Propagating properties under different incident angles and different period numbers for both Transverse Electric (TE) mode and Transverse Magnetic (TM) mode are studied. A photonic bandgap (PBG) is found between 450 and 700 nm. For both TE and TM modes, the blue shift can be found as the incident angle increases. The PC films are prepared by radio‐frequency (RF) magnetron sputtering experimentally. The experimental results are in accordance with the simulation results. The results indicate that the PBG is related to the incident angle and the period number, and increasing the period number is a feasible way to ensure the stability of the PBG. The studies are beneficial to the design of the PC filter in the future.
The EDIBLES survey
Authors: Elyajouri M. , Lallement R. , Cox N. L. J. , Cami J. , Cordiner M. A. , Smoker J. V. , Fahrang A. , Sarre P. J. , Linnartz H. 
Published: August 2018

Context. An unambiguous identification of the carriers of the diffuse interstellar bands (DIBs) would provide important clues to the life cycle of interstellar matter. The so-called C2-DIBs are a class of very weak bands that fall in the blue part of the optical spectrum and are associated with high column densities of the C2 molecule. DIB profile structures constrain potential molecular carriers, but their measurement requires high signal-to-noise, high-resolution spectra and the use of sightlines without Doppler splitting, as typical for a single-cloud situation.
Aims. Spectra from the ESO Diffuse Interstellar Bands Large Exploration Survey (EDIBLES) conducted at the Very Large Telescope (ESO/Paranal) were explored to identify single-cloud and high C2 column sightlines, extract the corresponding C2-DIBs and study their strengths and profiles, and to investigate in detail any sub-structures.
Methods. The target selection was made based on profile-fitting of the 3303 and 5895 Å Na I doublets and the detection of C2 lines. The C2 (2–0) (8750–8849 Å) Phillips system was fitted using a physical model of the host cloud. C2 column densities, temperatures as well as gas densities were derived for each sightline.
Results. Eighteen known C2-DIBs and eight strong non-C2 DIBs were extracted towards eight targets, comprising seven single-cloud and one multi-cloud line-of-sights. Correlational studies revealed a tight association of the former group with the C2 columns, whereas the non-C2 DIBs are primarily correlated with reddening. We report three new weak diffuse band candidates at 4737.5, 5547.4, and 5769.8 Å. We show for the first time that at least 14 C2-DIBs exhibit spectral sub-structures which are consistent with unresolved rotational branches of molecular carriers. The variability of their peak separations among the bands for a given sightline implies that their carriers are different molecules with quite different sizes. We also illustrate how profiles of the same DIB vary among targets and as a function of physical parameters, and provide tables defining the sub-structures to be compared with future models and experimental results.
CO destruction in protoplanetary disk midplanes: Inside versus outside the CO snow surface
Authors: Bosman Arthur D. , Walsh Catherine , van Dishoeck Ewine F. 
Published: August 2018

Context. The total gas mass is one of the most fundamental properties of disks around young stars, because it controls their evolution and their potential to form planets. To measure disk gas masses, CO has long been thought to be the best tracer as it is readily detected at (sub)mm wavelengths in many disks. However, inferred gas masses from CO in recent ALMA observations of large samples of disks in the 1–5 Myr age range seem inconsistent with their inferred dust masses. The derived gas-to-dust mass ratios from CO are between one and two orders of magnitude lower than the ISM value of ~100 even if photodissociation and freeze-out are included. In contrast, Herschel measurements of hydrogen deuteride line emission of a few disks imply gas masses in line with gas-to-dust mass ratios of 100. This suggests that at least one additional mechanism is removing CO from the gas phase.
Aims. Here we test the suggestion that the bulk of the CO is chemically processed and that the carbon is sequestered into less volatile species such as CO2, CH3OH, and CH4 in the dense, shielded midplane regions of the disk. This study therefore also addresses the carbon reservoir of the material which ultimately becomes incorporated into planetesimals.
Methods. Using our gas-grain chemical code, we performed a parameter exploration and follow the CO abundance evolution over a range of conditions representative of shielded disk midplanes.
Results. Consistent with previous studies, we find that no chemical processing of CO takes place on 1–3 Myr timescales for low cosmic-ray ionisation rates, <5 × 10−18 s−1. Assuming an ionisation rate of 10−17 s−1, more than 90% of the CO is converted into other species, but only in the cold parts of the disk below 30 K. This order of magnitude destruction of CO is robust against the choice of grain-surface reaction rate parameters, such as the tunnelling efficiency and diffusion barrier height, for temperatures between 20 and 30 K. Below 20 K there is a strong dependence on the assumed efficiency of H tunnelling.
Conclusions. The low temperatures needed for CO chemical processing indicate that the exact disk temperature structure is important, with warm disks around luminous Herbig stars expected to have little to no CO conversion. In contrast, for cold disks around sun-like T Tauri stars, a large fraction of the emitting CO layer is affected unless the disks are young (<1 Myr). This can lead to inferred gas masses that are up to two orders of magnitude lower. Moreover, unless CO is locked up early in large grains, the volatile carbon composition of the icy pebbles and planetesimals forming in the midplane and drifting to the inner disk will be dominated by CH3OH, CO2 and/or hydrocarbons.
Linked color imaging reduces the miss rate of neoplastic lesions in the right colon: a randomized tandem colonoscopy study
Authors: Paggi Silvia , Mogavero Giuseppe , Amato Arnaldo , Rondonotti Emanuele , Andrealli Alida , Imperiali Gianni , Lenoci Nicoletta , Mandelli Giovanna , Terreni Natalia , Conforti Francesco , Conte Dario , Spinzi Giancarlo , Radaelli Franco 
Published: August 2018

Abstract
Background Linked color imaging (LCI) is a newly developed image-enhancing endoscopy technology that provides bright endoscopic images and increases color contrast. We investigated whether LCI improves the detection of neoplastic lesions in the right colon when compared with high definition white-light imaging (WLI).
Methods Consecutive patients undergoing colonoscopy were randomized (1:1) after cecal intubation into right colon inspection at first pass by LCI or by WLI. At the hepatic flexure, the scope was reintroduced to the cecum under LCI and a second right colon inspection was performed under WLI in previously LCI-scoped patients (LCI–WLI group) and vice versa (WLI–LCI group). Lesions detected on first- and second-pass examinations were used to calculate detection and miss rates, respectively. The primary outcome was the right colon adenoma miss rate.
Results Of the 600 patients enrolled, 142 had at least one adenoma in the right colon, with similar right colon adenoma detection rates (r-ADR) in the two groups (22.7 % in LCI–WLI and 24.7 % in WLI–LCI). At per-polyp analysis, double inspection of the right colon in the LCI–WLI and WLI–LCI groups resulted in an 11.8 % and 30.6 % adenoma miss rate, respectively (P < 0.001). No significant difference in miss rate was found for advanced adenomas or sessile serrated lesions. At per-patient analysis, at least one adenoma was identified in the second pass only (incremental ADR) in 2 of 300 patients (0.7 %) in the LCI – WLI group and in 13 of 300 patients (4.3 %) in the WLI – LCI group (P = 0.01).
Conclusions LCI could reduce the miss rate of neoplastic lesions in the right colon.
Outcomes after endoscopic resection of large laterally spreading lesions of the papilla and conventional ampullary adenomas are equivalent
Authors: Klein Amir , Qi Zhengyan , Bahin Farzan , Awadie Halim , Nayyar Dhruv , Ma Michael , Voermans Rogier , Williams Stephen , Lee Eric , Bourke Michael 
Published: August 2018

Abstract
Background Endoscopic resection of ampullary adenomas is a safe and effective alternative to surgical resection. A subgroup of patients have large laterally spreading lesions of the papilla Vateri (LSL-P), which are frequently managed surgically. Data on endoscopic resection of LSL-P are limited and long-term outcomes are unknown. The aim of this study was to compare the outcomes of endoscopic resection of LSL-P with those of standard ampullary adenomas.
Methods A retrospective analysis of a prospectively collected and maintained database was conducted. LSL-P was defined as extension of the lesion ≥ 10 mm from the edge of the ampullary mound. Piecemeal endoscopic mucosal resection of the laterally spreading component was followed by resection of the ampulla. Patient, lesion, and procedural data, as well as results of endoscopic follow-up, were collected.
Results 125 lesions were resected. Complete endoscopic resection was achieved in 97.6 % at the index procedure (median lesion size 20 mm, interquartile range [IQR] 13 – 30 mm). Compared with ampullary adenomas, LSL-Ps were significantly larger (median 35 mm vs. 15 mm), contained a higher rate of advanced pathology (38.6 % vs. 18.5 %), and had higher rates of intraprocedural bleeding (50 % vs. 24.7 %) and delayed bleeding (25.0 % vs. 12.3 %). Both groups had similar rates of histologically proven recurrence at first surveillance (16.4 % vs. 17.9 %). Median follow-up for the entire cohort was 18.5 months. For patients with at least two surveillance endoscopies (n = 68; median follow-up 29 months, IQR 18 – 48 months), 95.6 % were clear of disease and considered cured.
Conclusions LSL-P can be resected endoscopically with comparable outcomes to standard ampullectomy, albeit with a higher risk of bleeding. Endoscopic treatment should be considered as an alternative to surgical resection, even for large LSL-P.
Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial
Authors: Walter Daisy , van den Berg Maarten , Hirdes Meike , Vleggaar Frank , Repici Alessandro , Deprez Pierre , Viedma Bartolomé , Lovat Laurence , Weusten Bas , Bisschops Raf , Haidry Rehan , Ferrara Elisa , Sanborn Keith , O’Leary Erin , van Hooft Jeanin , Siersema Peter 
Published: August 2018

Abstract
Background Dilation is the standard of care for recurrent benign esophageal strictures (BES). Biodegradable stents may prolong the effect of dilation and reduce recurrences. Efficacy and safety of dilation and biodegradable stent placement early in the treatment algorithm of recurrent BES were compared.
Methods This multicenter, randomized study enrolled patients with BES treated with previous dilations to ≥ 16 mm. The primary end point was number of repeat endoscopic dilations for recurrent stricture within 3 and 6 months. Secondary outcomes through 12 months included safety, time to first dilation for recurrent stricture, dysphagia, and level of activity.
Results At 3 months, the biodegradable stent group (n = 32) underwent significantly fewer endoscopic dilations for recurrent stricture compared with the dilation group (n = 34; P < 0.001). By 6 months, the groups were similar. The number of patients experiencing adverse events was similar between the groups. Two patients in the biodegradable stent group died after developing tracheoesophageal fistulas at 95 and 96 days post-placement; no deaths were attributed to the stent. Median time to first dilation of recurrent stricture for the biodegradable stent group was significantly longer (106 vs. 41.5 days; P = 0.003). Dysphagia scores improved for both groups. Patients in the biodegradable stent group had a significantly higher level of activity through 12 months (P < 0.001).
Conclusion Biodegradable stent placement is associated with temporary reduction in number of repeat dilations and prolonged time to recurrent dysphagia compared with dilation. Additional studies are needed to better define the exact role of biodegradable stent placement to treat recurrent BES.
Reliability and accuracy of a novel classification system using peroral cholangioscopy for the diagnosis of bile duct lesions
Authors: Robles-Medranda Carlos , Valero Manuel , Soria-Alcivar Miguel , Puga-Tejada Miguel , Oleas Roberto , Ospina-Arboleda Jesenia , Alvarado-Escobar Haydee , Baquerizo-Burgos Jorge , Robles-Jara Carlos , Pitanga-Lukashok Hannah 
Published: August 2018

Abstract
Background The aim of this study was to propose a novel, comprehensive, macroscopic classification for bile duct lesions.
Methods A two-stage protocol was designed. In Stage I, a retrospective study (September 2013 to September 2015) of patients with bile duct lesions detected by peroral cholangioscopy (POCS) was performed. A total of 315 images with at least 6 months of follow-up were recorded, analyzed, and correlated to histology, and were classified as non-neoplastic (one of three types, 1 – 3) or neoplastic (one of four types, 1 – 4) based on morphological and vascular patterns. In Stage II, a prospective, nonrandomized, double-blind study was performed from December 2015 to December 2016 to validate the proposed classification. Sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively), and positive and negative likelihood ratios (LR + and LR – , respectively) were calculated (gold standard: 6-month follow-up). Inter- and intraobserver agreement (kappa value, κ) among experts and non-experts were calculated.
Results 171 patients were included (65 retrospective; 106 prospective). In Stage I, 28/65 cases were neoplastic and 37 /65 were non-neoplastic, according to the final diagnosis. In Stage II, 56/106 were neoplastic with a sensitivity, specificity, PPV, NPV, LR + , and LR – for neoplastic diagnosis of 96.3 %, 92.3 %, 92.9 %, 96 %, 12.52, and 0.04, respectively. The proposed classification presented high reproducibility among observers, for both neoplastic and subtypes categories. However, it was better for experts (κ > 80 %) than non-experts (κ 64.7 % – 81.9 %).
Conclusion The novel classification system could help physicians to distinguish non-neoplastic from neoplastic bile duct lesions.
Evaluation of genotoxicity related to oral methylene blue chromoendoscopy
Authors: Repici Alessandro , Ciscato Camilla , Wallace Michael , Sharma Prateek , Anderloni Andrea , Carrara Silvia , Di Leo Milena , Hassan Cesare 
Published: August 2018

Abstract
Background An oral formulation of methylene blue with colonic delivery (MB-MMX) has been developed to increase detection of colorectal polys during colonoscopy. Traditionally, there have been safety concerns regarding DNA damage when methylene blue is exposed to white light. The aim of this study was to evaluate DNA damage in colonic mucosa after MB-MMX chromoendoscopy.
Methods This was an open-label phase II safety study to assess for genotoxicity on colorectal biopsies of patients undergoing two sequential colonoscopies before and after an oral dose of 200 mg MB-MMX added to their bowel prep. Analysis of a biomarker of double-stranded DNA breaks, γH2AX, was performed on biopsy specimens.
Results Ten patients were included in the study. The mean expression of γH2AX ± 95 % confidence intervals of the 50 biopsies before and after MB-MMX administration were 0.58 ± 0.08 and 0.62 ± 0.09, respectively (P = 0.24). None of the analyzed samples showed excess positive γH2AX expression, confirming the absence of DNA damage on biopsies after methylene blue exposure. No deaths or serious adverse events occurred.
Conclusions An oral dose of 200 mg of MB-MMX did not result in any detectable DNA damage.
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Authors: Gass Paul , Untch Michael , Müller Volkmar , Möbus Volker , Thomssen Christoph , Häberle Lothar , Erber Ramona , Hein Alexander , Jud Sebastian , Lux Michael , Hack Carolin , Hartmann Arndt , Kolberg Hans-Christian , Ettl Johannes , Lüftner Diana , Jackisch Christian , Beckmann Matthias , Janni Wolfgang , Schneeweiss Andreas , Fasching Peter , Nabieva Naiba 
Published: August 2018

Abstract
Background In women with early breast cancer, a pathological complete response (pCR) after neoadjuvant chemotherapy is reported to be associated with an improvement of the survival. The aim of this survey among physicians was to investigate whether the probability of achieving pCR in patients with a hormone receptor-positive, HER2-negative disease encourages physicians to recommend neoadjuvant chemotherapy.
Methods The study was conducted via an online survey that was sent to 493 physicians, who were either known as members of national guideline committees, heads of breast cancer centers, being high recruiters in clinical trials or leading a private practice. Participants were asked about a specific case that should resemble patients for whom it is unclear, whether they should be treated with chemotherapy.
Results 113 (24.5%) physicians participated at the survey, out of which 96.5% had a work experience of more than 10 years and 94.7% were board certified in their specialty. A total of 84.1% would consider pCR for a decision concerning neoadjuvant chemotherapy. With regard to the pCR probability, 2.7 and 10.6% of the participants demanded at least a pCR rate of 5 and 10%, respectively, while 25.7% were satisfied with 20% probability, and another 25.7% with a pCR rate of 30%.
Conclusions The vast majority of the long-term experienced physicians would embrace the implementation of a further method such as the prediction of pCR probability in clinical routine to support decision making regarding the necessity of neoadjuvant chemotherapy. The cut-off of around 30% pCR probability seems to be a realizable rate to distinguish patient groups.
Leitlinien „Chorea/Morbus Huntington“ für die deutschsprachigen Länder neu überarbeitet
Authors: Saft Carsten , Bonelli Raphael , Burgunder Jean-Marc , Dose Matthias , Epplen Jörg , Jung Hans , Priller Josef , Reilmann Ralf , Rudnik Sabine , Seppi Klaus , Landwehrmeyer G. Bernhard 
Published: August 2018

ZusammenfassungDie neu überarbeiteten Leitlinien Chorea/Morbus Huntington geben auf S2k Niveau einen Überblick über den Stand der Forschung zum Erkrankungsverlauf sowie zu neuen Ansätzen der symptomatischen und verlaufsmodifizierenden Therapie bei der Huntington-Krankheit. Im Gegensatz zu vielen anderen Leitlinien bevorzugen die Autoren aus den deutschsprachigen Ländern als Erstlinienbehandlung der Chorea Tiaprid. Aufgrund von Nebenwirkungen, welche unter Tetrabenazin auftreten können – wie etwa Depression oder Akathisie, ist es gängige Praxis, Tetrabenazin erst in zweiter Linie einzusetzen. Die Leitlinien nehmen Stellung zu rechtlichen Fragen der Präimplantationsdiagnostik (PID) und der pränatalen Diagnostik (PD) in Deutschland, Österreich und der Schweiz sowie zu den Unterschieden zwischen dem prädiktiven und dem differenzialdiagnostischen Einsatz der molekulargenetischen Diagnostik. In den Leitlinien wird darüber hinaus sehr ausführlich zu den möglichen Differenzialdiagnosen bei einer Chorea ungeklärter Ätiologie Stellung genommen.
Between Scylla and Charybdis: Charting the Wicked Problem of Reusing Health Data for Clinical Research Informatics
Authors: Lea Nathan , Nicholls Jacqueline , Fitzpatrick Natalie 
Published: August 2018

Objectives: Recognising dilemmas posed by the sharing and reuse of health data as a classic wicked problem and uncover some current key challenges to clinical research informatics.
Methods: A modified thematic review process including identification of agreed critical research questions, appropriate query terms and search strategy, identification of relevant papers in accordance with inclusion criteria, and authors' co-review of full text papers.
Results: Queries returned 4,779 papers published between January 2014 and November 2017. A shortlist of 197 abstracts was analysed and 18 papers were finally selected for review. Thematic assessment of findings revealed four key challenges: (1) uncertain reliability of consent as a cornerstone of trust due to the limits to understanding and awareness of data sharing; (2) ethical challenges around equity and autonomy; (3) ambitious overly theoretical governance frameworks lacking practical validity; and (4) a clear desire for further public and individual engagement to achieve clearer and more nuanced knowledge dissemination around data sharing practice and governance frameworks.
Conclusions: Understanding the wicked problem of reusing clinically acquired health data for research purposes is essential if clinical research is to benefit from informatics advances. A lack of understanding around the context of data acquisition and sharing undermines the foundations of patient-professional trust. Efforts to protect privacy, where tailoring to specific contexts is a key driver, should support the development of solutions which more adequately honour privacy needs, justify access, and protect equity and autonomy.
Clinical Research Informatics: Contributions from 2017
Authors: Daniel Christel , Kalra Dipak ,   Section Editors for the IMIA Yearbook Section on Clinical Research Informatics
Published: August 2018

Objectives: To summarize key contributions to current research in the field of Clinical Research Informatics (CRI) and to select best papers published in 2017.
Method: A bibliographic search using a combination of MeSH descriptors and free terms on CRI was performed using PubMed, followed by a double-blind review in order to select a list of candidate best papers to be then peer-reviewed by external reviewers. A consensus meeting between the two section editors and the editorial team was organized to finally conclude on the selection of best papers.
Results: Among the 741 returned papers published in 2017 in the various areas of CRI, the full review process selected five best papers. The first best paper reports on the implementation of consent management considering patient preferences for the use of de-identified data of electronic health records for research. The second best paper describes an approach using natural language processing to extract symptoms of severe mental illness from clinical text. The authors of the third best paper describe the challenges and lessons learned when leveraging the EHR4CR platform to support patient inclusion in academic studies in the context of an important collaboration between private industry and public health institutions. The fourth best paper describes a method and an interactive tool for case-crossover analyses of electronic medical records for patient safety. The last best paper proposes a new method for bias reduction in association studies using electronic health records data.
Conclusions: Research in the CRI field continues to accelerate and to mature, leading to tools and platforms deployed at national or international scales with encouraging results. Beyond securing these new platforms for exploiting large-scale health data, another major challenge is the limitation of biases related to the use of “real-world” data. Controlling these biases is a prerequisite for the development of learning health systems.